Figure 1.
Workflow for the derivation of the bioactivity descriptors for the in vivo toxicity CP models. For each biological assay, a conformal prediction model is built and used to predict the p-values of the compounds in the three in vivo endpoint data sets. These predicted p-values are used as bioactivity descriptors, in combination with chemical descriptors, for training the models of the in vivo endpoints.
